Gilead Sciences bags USFDA nod for Sunlenca to treat HIV-1 infection Ruchika Sharma23 Dec 2022 4:09 PM ISTLenacapavir is a breakthrough innovation with the potential to be a preferred and versatile foundational long-acting agent due to its therapeutic...
Kite Pharma, Daiichi Sankyo revise YESCARTA CAR T-Cell Therapy licensing agreement Ruchika Sharma11 Dec 2022 2:15 PM ISTTokyo: Kite Pharma, Inc., a Gilead Company, (hereafter Kite), and Daiichi Sankyo Co., Ltd. have jointly announced the revision of their 2017...
US Supreme Court rejects Bristol Myers cancer drug Yescarta patent fight with Gilead Sciences Ruchika Sharma8 Nov 2022 4:30 PM ISTA Gilead spokesperson said the company was pleased with the Supreme Court's decision, which has "effectively ended" the dispute.
Gilead Sciences Trodelvy under USFDA priority review for adult patients with pretreated metastatic breast cancer Ruchika Sharma14 Oct 2022 2:30 PM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
USFDA approves Kite retroviral vector manufacturing facility in Southern California for commercial production Ruchika Sharma5 Oct 2022 12:52 PM ISTThe Oceanside site is part of Kite’s global commercial manufacturing network that includes facilities in El Segundo, California, Amsterdam,...
Gilead Sciences widens battle against alleged counterfeit HIV drug ring Ruchika Sharma1 Oct 2022 9:30 AM ISTMany counterfeit bottles contain antiviral pills manufactured by Gilead but illegally bought off the street and repackaged, while some have been found...
Shilpa Medicare gets USFDA nod for Tenofovir Alafenamide Tablets Ruchika Sharma19 Sept 2022 11:25 AM ISTNew Delhi: Shilpa Medicare has recently announced that the Company has received U.S Food and Drug Administration (USFDA) tentative approval for...
Gilead Sciences settles patent disputes with Lupin, Cipla and 3 others over HIV, Hepatitis B drugs generic versions Ruchika Sharma16 Sept 2022 5:28 PM ISTThe generic drugmakers argued that the patents were invalid and unenforceable. They said in an August court filing that Gilead's patents covered...
Gilead Sciences' Kite gets European Commission nod for CAR T-cell therapy Tecartus Ruchika Sharma8 Sept 2022 4:00 PM ISTSanta Monica, Calif.: Kite, a Gilead Company has announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus...
Gilead Sciences bags European Commission nod for HIV drug Sunlenca Ruchika Sharma23 Aug 2022 1:30 PM ISTSunlenca is indicated in the European Union for the treatment of adults with multi-drug resistant HIV infection in combination with other...
Gilead Sciences to acquire MiroBio for Rs 3225 crore Ruchika Sharma9 Aug 2022 11:00 AM ISTThe acquisition will provide Gilead with MiroBio's proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists.
Gilead Sciences drug Trodelvy modestly delays breast cancer progression in late-stage trial Ruchika Sharma6 Jun 2022 4:09 PM ISTWall Street analysts, on average, expect annual sales of the drug will top $2 billion 2026, according to Refinitiv.
